|
[1] SIMMONDS P,BUKH J,COMBET C,et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes[J]. Hepatology,2005,42(4):962-973.
|
|
[2] COX AL,NETSKI DM,MOSBRUGER T,et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection[J]. Clin Infect Dis,2005,40(7):951-958.
|
|
[3] LUCIFORA J,PROTZER U. Attacking hepatitis B virus cccDNA-The holy grail to hepatitis B cure[J]. J Hepatol,2016,64(1 Suppl):s41-s48.
|
|
[4] SUN D,NASSAL M. Stable HepG2-and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus[J]. J Hepatol,2006,45(5):636-645.
|
|
[5] WERLE-LAPOSTOLLE B,BOWDEN S,LOCARNINI S,et al.Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy[J].Gastroenterology,2004,126(7):1750-1758.
|
|
[6] BOWDEN S,JACKSON K,LITTLEJOHN M,et al. Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR[J]. Methods Mol Med,2004,95:41-50.
|
|
[7] SINGH M,DICAIRE A,WAKIL AE,et al. Quantitation of hepatitis B virus(HBV)covalently closed circular DNA(cccDNA)in the liver of HBV-infected patients by LightCycler real-time PCR[J]. J Virol Methods,2004,118(2):159-167.
|
|
[8] CAI D,NIE H,YAN R,et al. A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures[J]. Methods Mol Biol,2013,1030:151-161.
|
|
[9] VOLZ T,ALLWEISS L,BEN MM,et al. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus[J]. J Hepatol,2013,58(5):861-867.
|
|
[10] KOCK J,SCHLICHT HJ. Analysis of the earliest steps of hepadnavirus replication:Genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity[J].J Virol,1993,67(8):4867-4874.
|
|
[11] ADDISON WR,WONG WW,FISCHER KP,et al. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus[J]. Antiviral Res,2000,48(1):27-37.
|
|
[12] XU CH,LI ZS,DAI JY,et al. Nested real-time quantitative polymerase chain reaction assay for detection of hepatitis B virus covalently closed circular DNA[J]. Chin Med J(Engl),2011,124(10):1513-1516.
|
|
[13] WONG DK,HUANG FY,LAI CL,et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma[J]. Hepatology,2011,54(3):829-836.
|
|
[14] GUO Y,SHENG S,NIE B,et al. Development of magnetic capture hybridization and quantitative polymerase chain reaction for hepatitis B virus covalently closed circular DNA[J].Hepat Mon,2015,15(1):e23729.
|
|
[15] MU D,YAN L,TANG H,et al. A sensitive and accurate quantification method for the detection of hepatitis B virus covalently closed circular DNA by the application of a droplet digital polymerase chain reaction amplification system[J]. Biotechnol Lett,2015,37(10):2063-2073.
|
|
[16] HUANG JT,YANG Y,HU YM,et al. A highly sensitive and robust method for hepatitis B virus covalently closed circular DNA detection in single cells and serum[J]. J Mol Diagn,2018,20(3):334-343.
|
|
[17] BAUMERT TF,MEREDITH L,NI Y,et al. Entry of hepatitis B and C viruses-recent progress and future impact[J]. Curr Opin Virol,2014,4:58-65.
|
|
[18] LAMAS LONGARELA,SCHMIDT TT,SCHONEWEIS K,et al.Proteoglycans act as cellular hepatitis delta virus attachment receptors[J]. PLo S One,2013,8(3):e58340.
|
|
[19] ZHONG Y,HAN J,ZOU Z,et al. Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR[J]. Clin Chim Acta,2011,412(21-22):1905-1911.
|
|
[20] ZHONG Y,HU S,XU C,et al. A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR[J]. BMC Infect Dis,2014,14:608.
|
|
[21] YEH CT,CHIU HT,CHU CM,et al. G1 phase dependent nuclear localization of relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA[J]. J Med Virol,1998,55(1):42-50.
|
|
[22] ZHANG X,LU W,ZHENG Y,et al. In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection[J]. J Clin Invest,2016,126(3):1079-1092.
|
|
[23] LAI CL,WONG D,IP P,et al. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B[J]. J Hepatol,2017,66(2):275-281.
|
|
[24] LIU S,ZHOU B,VALDES JD,et al. Serum hepatitis B virus RNA:A new potential biomarker for chronic hepatitis B virus infection[J]. Hepatology,2019,69(4):1816-1827.
|
|
[25] MAK LY,WONG DK,CHEUNG KS,et al. Review article:Hepatitis B core-related antigen(HBcrAg):An emerging marker for chronic hepatitis B virus infection[J]. Aliment Pharmacol Ther,2018,47(1):43-54.
|
|
[26] WOODDELL CI,YUEN MF,CHAN HL,et al. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBs Ag[J]. Sci Transl Med,2017,9(409). pii:eaan0241.
|
|
[27] CAVIGLIA GP,ABATE ML,TANDOI F,et al. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR:A new tool to detect occult infection[J]. J Hepatol,2018,69(2):301-307.
|
|
[28] ALLWEISS L,DANDRI M. The role of cccDNA in HBV maintenance[J]. Viruses,2017,9(6). pii:e156.
|
|
[29] NASSAL M. HBV cccDNA:Viral persistence reservoir and key obstacle for a cure of chronic hepatitis B[J]. Gut,2015,64(12):1972-1984.
|
|
[30] CHEN L,WU C,FAN X,et al. Replication and infectivity of hepatitis B virus in HBV-related glomerulonephritis[J]. Int J Infect Dis,2009,13(3):394-398.
|
|
[31] YU MM,GU XJ,XIA Y,et al. Relationship between HBV cccDNA expression in the human ovary and vertical transmission of HBV[J]. Epidemiol Infect,2012,140(8):1454-1460.
|
DownLoad: